Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Shares Outstanding (Diluted Average) (2021 - 2026)

Neuroone Medical Technologies filings provide 7 years of Shares Outstanding (Diluted Average) readings, the most recent being $8.5 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 64.37% to $8.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $8.5 million, a 64.37% increase, with the full-year FY2025 number at $40.2 million, up 50.03% from a year prior.
  • Shares Outstanding (Diluted Average) hit $8.5 million in Q1 2026 for Neuroone Medical Technologies, down from $50.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $50.3 million in Q4 2025 to a low of $5.2 million in Q1 2025.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $18.1 million (2023), compared with a mean of $23.7 million.
  • The widest YoY moves for Shares Outstanding (Diluted Average): up 77.7% in 2025, down 79.31% in 2025.
  • Neuroone Medical Technologies' Shares Outstanding (Diluted Average) stood at $16.2 million in 2022, then surged by 47.84% to $24.0 million in 2023, then increased by 28.69% to $30.9 million in 2024, then surged by 62.99% to $50.3 million in 2025, then crashed by 83.14% to $8.5 million in 2026.
  • The last three reported values for Shares Outstanding (Diluted Average) were $8.5 million (Q1 2026), $50.3 million (Q4 2025), and $40.2 million (Q3 2025) per Business Quant data.